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Background: Few studies have prospectively examined risk factors for posttraumatic stress disorder
(PTSD) in the aftermath of a traumatic exposure. The aim of this study is to identify the concurrent
inﬂuence of psychological and biological diatheses on PTSD onset and maintenance, taking into account
socio-demographic factors and psychiatric antecedents.
Methods: A total of 123 civilians (61.8% of women) recruited in emergency units, were assessed using
validated instruments during the ﬁrst week and then at 1, 4, and 12 months post-trauma. Baseline
assessment included evaluation of the psychological diathesis (i.e. psychiatric history and peritraumatic
distress and dissociation), and the biological diathesis [i.e. cortisol, norepinephrine, epinephrine, c-
reactive protein, total cholesterol, HDL cholesterol, glycosylated haemoglobin, waist-to-hip ratio (WHR),
body mass index, diastolic and systolic blood pressure (SBP), and heart rate].
Results: Multivariate logistic regression analyses demonstrated both psychological and biological di-
atheses to be independent risk factors for PTSD. Peritraumatic distress and dissociation predicted onset
(1-month) and mid-term PTSD (4-months), respectively. PTSD risk was associated positively with SBP
and negatively with WHR, throughout the follow-up. In addition, a higher level of 12 h-overnight urinary
norepinephrine independently predicted mid-term PTSD (4-months).
Conclusions: This prospective study shows that peritraumatic psychological and biological markers are
independent predictors of PTSD onset with speciﬁcities according to the stage of PTSD development; the
psychological diathesis, i.e. peritraumatic distress and dissociation, being a better predictor of short-term
dysfunction whereas biological diathesis was also predictive of development and maintenance of PTSD.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).lombiere, pav 42, 39, Avenue
5, France.
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Posttraumatic stress disorder (PTSD) occurs in people who have
experienced, witnessed, or been confronted with an event
involving actual or threatened danger. This event is followed by
speciﬁc symptoms which have been recently reclassiﬁed in four
diagnostic clusters in the DSM-5: re-experiencing, avoidance,
negative cognitions and mood, and arousal symptoms (American
Psychiatric Association, 2013). The majority of people exposed to
trauma however do not develop PTSD, most victimsmaintaining, or
rapidly returning to a normal functioning. The stressor initiates
traumatic memories, and the onset of PTSD symptoms actuallynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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hyperarousal and neurobiological cascade (McFarlane, 2000). This
transition phase is likely to be the period when risk and protective
factors are of greatest signiﬁcance (McFarlane, 2000) and conse-
quently an important window for intervention strategies, thus
stressing the importance of developing risk models at this stage.
PTSD is a heterogeneous disorder with variable expressions of
clinical distress immediately after exposure to a traumatic event
and thus variable clinical presentations. Two principal clinical
subtypes of PTSD have been described, primarily characterized
either by the expression of hyperarousal symptoms or by symp-
toms of dissociation, numbness and physiological unresponsive-
ness (Lanius et al., 2010a; Weston, 2014). These two sets of
symptoms are associated with different aspects of emotion dysre-
gulation and distinct patterns of physiological and brain activation
upon exposure to reminders of traumatic events (Lanius et al.,
2010b). The etiological factors of PTSD thus encompass both psy-
chological and biological aspects of the individual.
Of the theoretical diathesis-stress models proposed to identify
vulnerability factors or predictors of PTSD development, the most
recent models proposes that pre-trauma individual risk factors
(diatheses) contribute to a constitutional vulnerability to a situa-
tional stressor (trauma) (Bomyea et al., 2012; Elwood et al., 2009;
McKeever and Hiff, 2003). This stressor must be sufﬁciently se-
vere to activate the diathesis and promote the development of
PTSD. It is hypothesized that the less favorable the individual's
diathesis, the less severe will be the trauma susceptible to initiate
PTSD. According to Elwood et al. (2009) a comprehensive diathesis-
stress model of PTSD should take into account not only pre-, but
also peri- and post-trauma factors, as well as different types of
vulnerability (e.g. biological, psychological and cognitive) (Elwood
et al., 2009).
Predictors of psychological vulnerability were classiﬁed based
on the weighted effect sizes and temporal proximity with the
traumatic event. Peritraumatic distress (high level of emotion) and
peritraumatic dissociation (dissociative experiences) during or in
the immediate aftermath of the traumatic event are the most
proximal to the traumatic event. They were recognized as the most
robust predictors of PTSD symptoms (see for meta-analyses
(Brewin et al., 2000; Ozer et al., 2003)), more than other pre-
trauma factors (e.g. prior history of trauma, education, sex and
age) and a lynchpin in the development of PTSD symptoms
(Bremner et al., 1992; Marmar et al., 2006).
Regarding biological vulnerability, increased sympathetic ner-
vous system (SNS) and decreased hypothalamic-pituitary-adrenal
(HPA) functioning, within one month after trauma, have been re-
ported to contribute to PTSD onset and maintenance through the
formation of over-consolidated memories (Pitman, 1989). However
none of these factors has individually demonstrated the ability to
be amarker of PTSD development (Morris and Rao, 2013; Ostrowski
and Delahanty, 2014; Pitman et al., 2012). Another approach
considered the cost to the individual of adapting to cumulative
stress across a range of physiological systems (McEwen and Stellar,
1993). This cost or allostatic load (AL) refers to the cumulative
physiological wear and tear that results from repeated efforts of the
organism to adapt to stressors over time (McEwen and Stellar,
1993). AL is evaluated by assessing biomarkers of multiple sys-
tems including primary mediators of stress systems (e.g. cortisol,
epinephrine and norepinephrine) as well as biomarkers known to
exhibit change in response to interaction with a primary mediator
of stress (e.g. C-reactive protein (CRP)) or to represent secondary
outcomes of these mediating processes, namely systolic and dia-
stolic blood pressure (SBP and DBP, respectively), glycosylated
haemoglobin (HbA1c) and visceral fat depositing. Although high AL
was hypothesized to be a major contributor to the development ofPTSD (Charney, 2004; McEwen, 2002), this has not been demon-
strated. The validity of this concept is also questioned notably in the
ﬁeld of stress related disorders in which insufﬁcient glucocorticoid
signaling may play a signiﬁcant role in the etiology (Fries et al.,
2005; Heim et al., 2000; Raison and Miller, 2003).
Actually, it is becoming evident that simple biological models
could not account for the complex etiology of PTSD which should
consider together psychological and biological aspects and their
relative weight in the onset and maintenance of PTSD overtime.
However, to our knowledge, no study on PTSD etiology has studied
both aspects concurrently. Our prospective study aimed to examine
the effect of both psychological (psychiatric history and peri-
traumatic reaction) and a large range of potential markers of bio-
logical diatheses on PTSD onset (after 1-month) and maintenance
(4- and 12-months), in people who have recently experienced a
traumatic event of the civilian life, while taking into account soci-
odemographic pre-trauma factors.
2. Methods
2.1. Study population
People having experienced an event satisfying criterion A1 and
A2 for trauma exposure (DSM-IV) (American Psychiatric
Association, 1994) within the previous 7 days, were consecutively
recruited in the emergency and forensic medicine departments of
the Montpellier University Hospital (France) between 2006 and
2011 (the Phoenix study). The exclusion criteria were: 1) having
experienced signiﬁcant head injury deﬁned as an external injury to
the brain leading to a loss of consciousness for 10 min or more, 2)
previously suffering from a psychotic illness or mental retardation,
3) being homeless, 4) use of corticosteroid medications which
could interfere with cortisol measurement. A ﬁfth exclusion crite-
rion concerned domestic violence which is mostly woman speciﬁc,
frequently chronic and associated with high prevalence of current
PTSD which may introduce a methodological bias regarding cau-
sality. The study protocol was approved by the South-
Mediterranean Ethics Committee and written informed consent
was obtained from each participant.
Participants were administered standardized questionnaires by
a single Master level research nurse at baseline and after 1, 4 and 12
month of follow-up. The ﬁrst interview was within 2e7 days after
trauma exposure [median (IQR) ¼ 5 (4e6) days]. Venous blood
samples were collected during the interview and 12 h-overnight
urine during the subsequent night. Of the 123 individuals recruited,
89 completed the 1-month follow-up [median (IQR) ¼ 39 (30e49)
days], 85 the 4-month follow-up [median (IQR) ¼ 136 (123e152)
days], and 57 the 12-month follow-up [median (IQR) ¼ 387
(361e413) days]. The subjects lost to follow-up more frequently
reported lifetime psychiatric disorder (p < 0.05). Those lost spe-
ciﬁcally to the last follow-up after 12 months were also younger
(p ¼ 0.04) and with a higher peri-traumatic distress score
(p¼ 0.01). No other signiﬁcant differences were found between the
participants included in analyses and those lost to follow-up.
2.2. Interview
2.2.1. Inclusion examination
The standardized interview included questionnaires on socio-
demographic characteristics as well as clinical and biological
evaluation and information relating to prescription drug and psy-
chotherapy use over the last two years. Peritraumatic reaction and
psychiatric history were also investigated as part of this baseline
psychiatric evaluation. Peritraumatic distress was assessed using
the validated French version of the Peritraumatic Distress Inventory
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emotional response during and immediately after traumatic
exposure, using a 13 item on a 5-point Likert scale. Item scoreswere
summed to calculate the total score.
The validated French version of the Peritraumatic Dissociative
Experience Questionnaire (PDEQ) (Birmes et al., 2005), developed
by Marmar et al. (1997), evaluated dissociation at the time of the
trauma and immediately after. This self-reported questionnaire
includes perceptions of depersonalization, derealization, corporal
change, and altered notion of time. The subjects rate the 10 items
on a 5-point Likert scale and item scores were summed to calculate
the total score.
Lifetime and current DSM-IV diagnoses of Axis I disorders were
evaluated using a standardized psychiatric interview, the Mini In-
ternational Neuropsychiatric Interview (MINI, French version 5.00)
previously validated within the general population setting
(Lecrubier et al., 1997).
2.2.2. Follow-up visits
The Watson's PTSD Interview (PTSD-I) (Watson et al., 1991) was
used to diagnose current (during the month preceding the exami-
nation) PTSD using the validated French self-report version at each
follow-up (Brunet, 1995; Jehel et al., 1999). The traumatic event was
explored through 17 items corresponding to PTSD speciﬁc symp-
toms. Answers to each questionwere given on a 7-point Likert scale
ranging from “1-(never)” to “7-(extremely)”. PTSD-I can provide a
continuous measure of the severity of the disorder (a score of “4-
(commonly)”) is considered to be sufﬁcient to meet the relevant
DSM symptom criterion.
2.3. Biological and clinical markers
The current study is based on 12 biomarkers identiﬁed to
represent different contributing factors to allostatic load. Neuro-
endocrine 12-h overnight urinary excretion of markers, i.e.
cortisol, norepinephrine and epinephrine were normalized using
12-h urinary excretion of creatinine to adjust for variability in body
size and renal function. Cortisol concentration was determined by
radioimmunoassay kits (DSL 2100, Diagnostic Systems Labora-
tories, Inc, Webster, Texas, USA), and both norepinephrine and
epinephrinewere assessed by high pressure liquid chromatography
on preliminary acidiﬁed urine. Blood metabolic parameters
included HbA1c, assessed by high pressure liquid chromatography,
and high density lipoprotein-cholesterol (HDL-cholesterol) and
total cholesterol assessed by routine enzymatic methods.
Morphologic measures: Hip and waist circumferences and height
were measured by a tape-measure and weight using electronic
scales. Waist circumference was measured at the narrowest point
between the ribs and the iliac crest, and hip circumference was
measured at the maximal site around the buttocks. Body mass in-
dex (BMI) and waist-to-hip ratio (WHR) were calculated. Cardio-
vascular factors included resting heart rate as well as resting SBP
and DBP, calculated as the average of two seated recordings taken
by a nurse at least 30 min after the beginning of the interview. CRP
was used as a marker of systemic inﬂammation. High-sensitivity
CRP was measured by means of particle enhanced immunone-
phelometry assay. Participants with CRP levels >10 mg/L were
excluded from the analyses (n ¼ 6), as this high level of CRP was
considered to be owing to acute-phase response. All assays were
conducted by the department of Biochemistry, Lapeyronie Hospital,
Montpellier, France.
2.4. Statistical analysis
Classic statistically methods in epidemiology were used. Chi-square tests compared the characteristics of participants included
in the analyses with those excluded. Associations between baseline
participant characteristics (measured during the ﬁrst week after the
trauma) and acute (1-month), chronic mid-term (4-months) and
long-term PTSD (12-months) were ﬁrst assessed using logistic
regression models adjusted for sex and age. In a second step,
multivariate models included age, sex, and the baseline covariates
associated with PTSD in previous logistic regression models with a
p-value < 0.20. The linearity of the covariates was controlled using
the likelihood ratio test. Multivariate models were reduced using a
backward selection procedure. The models providing the best
goodness of ﬁt to the current dataset, as assessed using the Akaike
Information Criterion (AIC), were selected. The model ability to
properly classify the subjects was evaluated using an index of pre-
dictive discrimination, the concordance (c), that is identical to the
area under the curve. As in the case of an exploratory study, we have
not applied correction for multiple comparisons following the rec-
ommendations of several authors (Bender and Lange, 2001;
Rothman, 1990; Savitz and Olshan, 1998), corrections possibly
increasing the risk of type II errors. The analyses were undertaken
with the subjects having nomissing data on any covariates included
in the most complete model. Analyses were performed using SAS
statistical software (version 9.4; SAS Inc, Cary, North Carolina, USA).
3. Results
3.1. Baseline characteristics
The median age (Q25-Q75) was 36.5 years (26.8e47.1) with
61.8% of women (Table 1). Around 69% of subjects had experienced
an interpersonal trauma (physical and sexual assault) and 71.5%
reported at least one lifetime psychiatric disorder which was cur-
rent for 57.7%. Table 2 describes baseline biological characteristics
of the sample during the ﬁrst week following the traumatic event.
3.2. Risk factors for acute and chronic PTSD over 12-month follow-
up
Acute PTSD was diagnosed in 28.1% of the participants, 1-month
after the traumatic event, and chronic PTSD after 4- and 12-months
in 21.2% and 17.5% of the participants, respectively.
Regarding psychological characteristics in logistic regression
models adjusted for age and sex, both peritraumatic distress and
dissociation scores were associated with a 10% increased odds of
PTSD (for 1 unit score increase), at each wave of the follow-up
(Table 3). No signiﬁcant association was found with lifetime psy-
chiatric history (p > 0.51).
Examining biological and clinical markers individually, having
higher SBP, DBP, HbA1c and BMI were signiﬁcantly associated with
the odds of developing acute PTSD after 1 month (Table 3). Mid-
term chronic PTSD at 4 months was associated with higher SBP
and norepinephrine, and lower cortisol. A higher HbA1c also pre-
dicted chronic PTSD at 4 and 12months whereas a higherWHRwas
associated with a decreased odd of developing long-term chronic
PTSD at 12 months. No signiﬁcant associations were found with
heart rate, epinephrine, CRP, HDL- and total cholesterol.
3.3. Multivariate models
Multivariate analyses included age, sex and psychological vari-
ables (PDI and PDEQ) as well as cortisol, norepinephrine, HbA1c,
SBP, DBP, WHR and BMI which were found associated with PTSD in
minimally adjusted models. SBP was positively, and WHR nega-
tively associated with PTSD, consistently throughout the follow-up
(Table 4). It should be noted that in our study, all the variables are
Table 1
Baseline socio-demographic, trauma, and psychological characteristics of the cohort
(n ¼ 123).
Characteristics
Median age (Q25eQ75; years) 36.47 (26.84e47.05)
Female gender (%) 61.79
Education level >12 years (%) 47.15
Living alone (%) 21.95
Traumatic event type (%)
Physical assault 58.54
Sexual assault 10.57
Serious accident 13.01
Other 17.89
Peritraumatic reaction scores:
Median PDEQ (Q25-Q75) 24 (17e32)
Mean PDI (SD) 24.04 (10.20)
Psychiatric history (%):
Lifetime psychiatric history 71.54
Lifetime PTSD 8.13
Psychotropic use during the 2 last years 25.20
Abbreviations: PDEQ, Peritraumatic Dissociative Experience Questionnaire; PDI,
Peritraumatic Distress Inventory; PTSD, Posttraumatic Stress Disorder.
Table 2
Physiological characteristics of the cohort at baseline (n ¼ 123).
Biomarker (Unit) Median (Q25eQ75)
Urine:
Cortisol (mg/g creatinine) 38.93 (28.01e55.45)
Epinephrine (mg/g creatinine) 1.43 (0.70e3.37)
Norepinephrine (mg/g creatinine) 22.18 (16.31e32.79)
Blood:
Glycosylated haemoglobin (%) 5.30 (4.90e5.60)
C-reactive protein (mg/l) 1.30 (0.50e3.10)
Total Cholesterol (g/l) 1.90 (1.68e2.22)
HDL cholesterol (g/l) 0.61 (0.49e0.75)
Cardiovascular measures:
Systolic blood pressure (mm Hg) 120 (110e130)
Diastolic blood pressure (mm Hg) 70 (70e80)
Heart rate (bpm) 76 (67e80)
Morphometric measures:
WHR 0.92 (0.87e0.98)
BMI (kg/m2) 22.96 (20.31e25.70)
Abbreviations: BMI, body mass index; WHR, waist-to-hip ratio.
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sponded to 1 unit increase. For example in Table 4: SBP and PTSD
diagnosis at 12-months post-trauma; OR ¼ 1.11 [1.02e1.21], means
that the risk increased by 11% for an increase of SBP of only
1 mmHg. A signiﬁcant increased odd of chronic PTSD was also
observed with higher norepinephrine after 4 months. These asso-
ciations were independent of the peritraumatic reactionwhich was
also signiﬁcantly associated with PTSD; a higher baseline distress
score being predictive of acute PTSD after 1 month whereas a
higher dissociation score was predictive of mid-term chronic PTSD
after 4 months. The model concordance coefﬁcient which reﬂects
the ability to properly classify the subjects, was very good at each
follow-up including after 12 months (c ¼ 0.96).
4. Discussion
This prospective study showed that peritraumatic psychological
and biological markers are independent predictors of PTSD onset
with speciﬁcities according to the stage of PTSD development;
psychological markers were predictive of short- or mid-term PTSD
whereas biological markers were also predictive of long-term PTSD.
Among psychological markers, peritraumatic distress was pre-
dictive of acute PTSD, one month after the traumatic event,
whereas peritraumatic dissociation predicted mid-term PTSD at 4
months. Several studies have reported a signiﬁcant associationbetween peritraumatic distress or dissociation and PTSD symptom
severity or current diagnosis but very few studies have investigated
the dynamics of PTSD incidence over 1 year by examining the acute,
mid-term, and long-term chronic stages (Lensvelt-Mulders et al.,
2008; Ozer et al., 2003; Thomas et al., 2012; van der Hart et al.,
2008; van der Velden and Wittmann, 2008). Our ﬁndings on peri-
traumatic factors are in agreement with prospective studies
showing that PDI scores could predict acute PTSD symptoms 4e6
weeks post-trauma (Berna et al., 2012; Brunet et al., 2013; Bui et al.,
2010a) as well as with a recent meta-analysis suggesting a sys-
tematic decrease over time, in the correlation between PDI scores
and PTSD symptoms (Thomas et al., 2012). However, our data
contrast with one recent longitudinal study in 39 elderly people
suggesting that distress but not dissociation scores were predictive
of acute and chronic PTSD (Brunet et al., 2013). This study was
however limited by low statistical power and differs in cohort
characteristics, e.g. age, sex, as well as type and/or severity of the
traumatic events which may result in a lower dissociation score in
that study (Olff et al., 2007; Wittmann et al., 2006).
Overall, our study showed that peritraumatic distress and
dissociation are risk factors for PTSD development but not long-
term maintenance. These two markers could predict PTSD symp-
toms before the time of “crystallization” or chronicity of symptoms
(Bui et al., 2010b), in contrast with other factors including persis-
tent dissociation (Briere et al., 2005; Halligan et al., 2003; Murray
et al., 2002; O'Donnell et al., 2007), initial PTSD symptom severity
(Marshall and Schell, 2002), and social support (Ozer et al., 2003)
which have been reported to be better predictors of long-term
adjustment (Ozer et al., 2003).
Regarding biological diathesis, our multivariate analyses iden-
tiﬁed two types of independent biomarkers, those consistently
associated with PTSD onset and maintenance throughout the
follow-up, e.g. SBP and WHR, and one transient marker, e.g.
norepinephrine which was associated with 4-months PTSD diag-
nosis. These three biomarkers are individual components of AL but
they differently predicted speciﬁc phases of PTSD development.
A longitudinal study in 125 civilian victims failed to show a
signiﬁcant association between 4-h diurnal urinary cortisol and
norepinephrine levels collected immediately after trauma and
PTSD at 5 months (Shalev et al., 2008; Videlock et al., 2008). In the
other hand attenuated cortisol response during the early post-
traumatic period has been reported in minimally adjusted studies,
though not consistently (Bonne et al., 2003) to contribute to mid-
term SNS disruption in exposed individuals (Delahanty and
Nugent, 2006; Ehring et al., 2008; McFarlane et al., 2011;
Mouthaan et al., 2014; Yehuda, 2002). We also observed a nega-
tive association between cortisol and PTSD after 4 months which
was signiﬁcant in minimally adjusted model but which failed to be
signiﬁcant in multivariate model. Besides, the positive association
of norepinephrine with mid-term PTSD at 4 months remained
signiﬁcant independently of the other covariates. The in-
consistencies between the studies could reﬂect differences in
methodology (McFarlane et al., 2011); in most of the previous
studies biomarkers were collected in emergency room whereas in
our study they were collected 5 days post-trauma (IQR¼ 4e6). One
explanation could also be that there is a delayed time window for
the measurement of cortisol and catecholamine responses where
the effect of cortisol may be early and transient within a narrow
window immediately following the trauma (McFarlane et al., 2011).
In our study SBP, but not heart rate was an independent pre-
dictor of PTSD consistently throughout the follow-up. In theoretical
fear-conditioning models of PTSD, cardiovascular arousal in
response to the trauma has been linked to over-consolidation of
traumatic memories and subsequent PTSD (Charney et al., 1993).
Reports of an association between elevated heart rate or blood
Table 3
Logistic regression analysesa of biological and psychological markers associated with PTSD diagnosis during follow-up.
Variable (Unit) 1 month (n ¼ 89) 4 months (n ¼ 85) 12 months (n ¼ 57)
OR [95% CI] p-value OR [95% CI] p-value OR [95% CI] p-value
Education >12 years 0.64 [0.24e1.71] 0.378 0.48 [0.15e1.51] 0.210 0.48 [0.09e2.47] 0.382
Lifetime psychiatric history 0.93 [0.33e2.64] 0.895 1.50 [0.45e5.02] 0.514 0.68 [0.14e3.25] 0.626
Psychological reaction
Peritraumatic distress (score) 1.11 [1.04e1.18] 0.001 1.09 [1.02e1.16] 0.014 1.09 [0.99e1.20] 0.086
Peritraumatic dissociation (score) 1.08 [1.02e1.13] 0.004 1.13 [1.06e1.21] <0.001 1.09 [1.00e1.20] 0.055
12-h Urine
Cortisol (mg/g creatinine) 0.98 [0.96e1.01] 0.129 0.95 [0.91e0.99] 0.006 0.97 [0.93e1.01] 0.125
Norepinephrine (mg/g creatinine) 1.02 [0.99e1.06] 0.261 1.05 [1.01e1.09] 0.038 1.03 [0.96e1.09] 0.437
Epinephrine (mg/g creatinine) 1.03 [0.87e1.21] 0.751 1.05 [0.83e1.33] 0.708 0.95 [0.61e1.48] 0.823
Blood
Glycosylated haemoglobin (%) 1.14 [1.01e1.28]# 0.028 1.18 [1.04e1.34]# 0.010 1.19 [1.00e1.42]# 0.053
C-reactive protein (mg/l) 1.00 [0.83e1.22] 0.963 0.98 [0.78e1.22] 0.827 1.23 [0.89e1.70] 0.220
Total Cholesterol. 0.44 [0.11e1.71] 0.236 1.44 [0.30e6.93] 0.649 1.09 [0.14e8.42] 0.936
HDL cholesterol (g/l) 0.91 [0.70e1.19]# 0.495 1.06 [0.78e1.43]# 0.728 0.78 [0.48e1.26]# 0.303
Cardiovascular measures
Systolic BP (mm Hg) 1.05 [1.01e1.09] 0.007 1.07 [1.02e1.12] 0.005 1.05 [1.00e1.11] 0.070
Diastolic BP (mm Hg) 1.05 [1.01e1.10] 0.025 1.04 [1.00e1.09] 0.074 1.05 [0.98e1.12] 0.167
Heart rate (bpm) 1.01 [0.98e1.05] 0.507 1.00 [0.96e1.04] 0.986 1.00 [0.94e1.05] 0.868
Morphometric measures
WHR 0.58 [0.25e1.33]# 0.199 0.61 [0.25e1.52]# 0.292 0.15 [0.03e0.70]# 0.016
BMI (kg/m2) 1.13 [1.01e1.27] 0.031 1.08 [0.97e1.21] 0.172 1.15 [0.97e1.37] 0.110
All the variables are continuous variables and the OR corresponded to 1 unit increase except for # where OR corresponded to 0.1 unit increase.
Abbreviations: BMI, body mass index; BP, blood pressure; CI, conﬁdence interval; OR, odds ratio; WHR, waist-to-hip ratio.
Boldface type indicates signiﬁcance at p-value  0.05.
a Adjusted for age and sex.
Table 4
Multiple logistic regression analyses of biological and psychological markers associated with PTSD onset during the follow-up.
1 month post-trauma 4 months post-trauma 12 months post-trauma
OR [95% CI] p-value c OR [95% CI] p-value c OR [95% CI] p-value c
n ¼ 83 (24 cases) 0.84 n ¼ 77 (17 cases) 0.93 n ¼ 52 (9 cases) 0.96
Cortisol (mg/g creat.) e e 0.96 [0.91e1.01] 0.120 e e
NE (mg/g creat.) e e 1.07 [1.00e1.14] 0.041 e e
Systolic BP (mm Hg) 1.04 [1.01e1.07] 0.016 1.10 [1.00e1.20] 0.047 1.11 [1.02e1.21] 0.019
Diastolic BP (mm Hg) 0.94 [0.87e1.02] 0.150 0.92 [0.83e1.03] 0.147 e e
WHR# 0.29 [0.12e0.69] 0.005 0.12 [0.03e0.52] 0.005 0.03 [0.003e0.34] 0.004
BMI (kg/m2) 1.29 [1.01e1.66] 0.045
PDI score 1.09 [1.00e1.18] 0.040 e e e e
PDEQ score 1.06 [0.99e1.13] 0.104 1.21 [1.08e1.36] 0.002 e e
All the variables are continuous variables and the OR corresponded to 1 unit increase except for # where OR corresponded to 0.1 unit increase.
Abbreviations: BMI, Body Mass Index; BP, Blood Pressure; c, concordance value of the logistic model; creat., creatinine; NE, norepinephrine; PDEQ, Peritraumatic Dissociative
Experience Questionnaire; PDI, Peritraumatic Distress Inventory; WHR, waist-to-hip ratio.
Boldface type indicates signiﬁcance at p-value  0.05.
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inconsistent (Bryant, 2006; Bryant et al., 2008; Yehuda et al., 1998).
Our study differs from previous studies in several respects
regarding trauma type (interpersonal traumas vs. motor vehicle
accident in most previous studies), male/female ratio (approxi-
mately 1/2 vs. 2/1 in the others studies) and methodology (heart
rate and BP assessed around 5 days post-trauma vs. within a few
hours). Very few studies have examined cardiovascular parameters
in the aftermath of an acute stress exposure in ecological settings.
In a large population of patients with hypertension, September-11
attacks were associated with substantial and sustained increase
in blood pressure for 2 months (Gerin et al., 2005). Cardiovascular
reactions have also been reported among 185 military survival
trainees after a test of mock captivity including residual elevations
in SBP after 24 h of recovery especially in females (Taylor et al.,
2014). Whether a higher SBP found in our study is a “trait”
parameter, present prior to trauma or the result of prolonged
physiological arousal and failure of vulnerable subjects to restore
biological homeostasis remained to be determined. Individual dif-
ferences in recovery at more extended periods after a stressor mayactually have greater consequences than those observed shortly
after the stressor and a clear relationship may only be evident after
the non-pathological acute reaction has subsided.
In our study, a higher WHR was associated with a lower risk of
PTSD development and maintenance throughout all the follow-up
stages. Peters et al. recently showed that exposure to chronic
stress can result in two different phenotypes depending on genetic
background (Peters et al., 2013). The A-phenotype accumulates
visceral fat (high WHR) and does not habituate to chronic stress,
whereas the B-phenotype, once exposed to a stressful environ-
ment, habituates but needs to increase food intake in order to
maintain brain energy metabolism, subsequently accumulating
peripheral fat (high BMI). As habituation to stress reduces the
damaging effects of chronic stress, the risk of developing cardio-
vascular, metabolic and certain psychiatric diseases (e.g. typical
depression) in stressful environments associated with the B-
phenotype, would be globally lower (Peters et al., 2013). On the
other hand, the absence of habituation to stress in the A-phenotype
has been linked to higher cortisol secretion during exposure to
uncontrollable psychological stressors, notably in lean women
C. Gandubert et al. / Neurobiology of Stress 3 (2016) 61e6766(Epel et al., 2000). This suggests that a higher secretion of cortisol
during and/or immediately after the traumatic exposure, may
contribute to control of fear reactivity and thus lower PTSD risk as
also observed using exogenous corticosteroids (Amos et al., 2014;
Schelling et al., 2004; Suris et al., 2010). Establishing the signiﬁ-
cance of WHR in PTSD onset will require further investigation,
notably in relation with the time-dependent effects of cortisol on
the contextualization of emotional memories (Cornelisse et al.,
2014).
Our study has several strengths, notably a prospective design
with three follow-up waves over 12 months, and using standard-
ized diagnostic procedures based on a structured clinical interview.
This study has also for the ﬁrst time taken into account simulta-
neously the biological status and the psychological vulnerability of
the traumatized subjects. Participants experienced multiple trau-
matic events of civilian life in contrast with most previous studies
mainly focusing on motor vehicle accident exposure in which the
individual has not usually been speciﬁcally targeted (not interper-
sonal traumatic event).
The study however suffers from some limitations. Despite
repeated attempts to convene all participants at eachwave, 27.6% of
the subjects initially included were missing at any subsequent
follow-up. Of the 89 subjects with at least one follow-up, 85 (95.5%)
were still in the study after 4 months. The main drop-out occurred
at the last interview, with 64% of participants being followed-up
after 1 year. This attrition rate was similar to that of most other
studies in traumatized civilians. The subjects lost after 1 year only
differed by higher rate of lifetime psychiatric disorder at baseline
and having a higher peritraumatic distress score which may led to
an underestimation of the strength of the associations. Despite this
limitation, the concordance coefﬁcients were very good even after
1 year follow-up. We cannot exclude the possibility that other
factors not assessed in our study may also contribute to the
development of PTSD such as childhood events and acute stress
disorder, although peritraumatic dissociation, a distinctive feature
of acute stress disorder diagnosis, was considered. Finally, since
multiple analyses have been performed, we cannot exclude that
some associations were due to chance. However our results are also
supported by a strong physiopathological rationale.
5. Conclusion
This study suggests that the neurobiological mechanisms un-
derlying the development of PTSD are heterogeneous differing in
particular in relation to those initiating as opposed to those pro-
moting the maintenance of the psychopathology. Our ﬁndings
support the independent inﬂuence of both the psychological and
the biological diatheses in PTSD installation; the psychological
diathesis, i.e. peritraumatic distress and dissociation, being a better
predictor of short-term dysfunction whereas biological diathesis
appears rather to predict development and/or maintenance of
PTSD. An important translational aspect of our study lies in the fact
that most of the risk factors identiﬁed may be prevented by clinical
intervention, thus suggesting potential intervention windows for
prevention.
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